These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Corneal contact time of artificial tear solutions]. Marquardt R; Christ T Klin Monbl Augenheilkd; 1986 Sep; 189(3):254-7. PubMed ID: 3784417 [TBL] [Abstract][Full Text] [Related]
3. Diagnosis and primary care management of tear film deficiencies. Semes L Optom Clin; 1995; 4(3):87-104. PubMed ID: 7767022 [TBL] [Abstract][Full Text] [Related]
4. [Therapy of the dry eye]. Jaeger W Fortschr Ophthalmol; 1986; 83(1):126-7. PubMed ID: 3710343 [No Abstract] [Full Text] [Related]
5. [Scanning electron microscopy studies of the effectiveness of artificial tears]. Brewitt H; Joost P Fortschr Ophthalmol; 1987; 84(2):150-4. PubMed ID: 3596412 [No Abstract] [Full Text] [Related]
6. Recent developments in dry eye management. Lemp MA Ophthalmology; 1987 Oct; 94(10):1299-304. PubMed ID: 3317182 [TBL] [Abstract][Full Text] [Related]
7. An improved method for the delivery of artificial tears using an infusion pump. Karesh JW; Nirankari VS Invest Ophthalmol Vis Sci; 1986 Aug; 27(8):1284-8. PubMed ID: 3733371 [TBL] [Abstract][Full Text] [Related]
8. Color discrimination in patients with keratoconjunctivitis sicca before and after artificial tear application. Rieger G Wien Klin Wochenschr; 1998 Apr; 110(8):296-7. PubMed ID: 9615962 [TBL] [Abstract][Full Text] [Related]
9. Treatments of keratoconjunctivitis sicca. Nelson JD Arch Ophthalmol; 1985 Nov; 103(11):1630-1. PubMed ID: 4062625 [No Abstract] [Full Text] [Related]
11. Topical 0.1% prednisolone lowers nerve growth factor expression in keratoconjunctivitis sicca patients. Lee HK; Ryu IH; Seo KY; Hong S; Kim HC; Kim EK Ophthalmology; 2006 Feb; 113(2):198-205. PubMed ID: 16360211 [TBL] [Abstract][Full Text] [Related]
12. Guidelines for the treatment of chronic dry eye disease. Sheppard JD Manag Care; 2003 Dec; 12(12 Suppl):20-5. PubMed ID: 14723110 [TBL] [Abstract][Full Text] [Related]
13. [Use of a new gel tear substitute in ophthalmology and intensive medicine]. Christ T; Marquardt R Fortschr Ophthalmol; 1987; 84(4):335-9. PubMed ID: 3509989 [No Abstract] [Full Text] [Related]
14. General measures in management of the dry eye. Lemp MA Int Ophthalmol Clin; 1987; 27(1):36-43. PubMed ID: 3818199 [No Abstract] [Full Text] [Related]
15. Biomicroscopy of the tear film: aqueous and lipid tear substitutes in the normal and abnormal eye. Carrington S; Bedford PG; Guillon JP; Carlile JL; Woodward EG Vet Rec; 1988 Sep; 123(13):329-35. PubMed ID: 3195015 [TBL] [Abstract][Full Text] [Related]
16. Tear film: new concepts and implications for the management of the dry eye. Lemp MA Trans New Orleans Acad Ophthalmol; 1987; 35():53-64. PubMed ID: 3441945 [No Abstract] [Full Text] [Related]
17. Evaluation and differential diagnosis of keratoconjunctivitis sicca. Lemp MA J Rheumatol Suppl; 2000 Dec; 61():11-4. PubMed ID: 11128698 [TBL] [Abstract][Full Text] [Related]
18. Effect of topical 0.02% tacrolimus aqueous suspension on tear production in dogs with keratoconjunctivitis sicca. Berdoulay A; English RV; Nadelstein B Vet Ophthalmol; 2005; 8(4):225-32. PubMed ID: 16008701 [TBL] [Abstract][Full Text] [Related]
20. [Treatment of dry eye with a new gel in eyedrop form]. Marquardt R Klin Monbl Augenheilkd; 1986 Jul; 189(1):51-4. PubMed ID: 3761978 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]